This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Researchers from the University of Turku used the latest genome-wide methods to examine a pair of twins’ blood samples for any disease-related differences in epigenetic to help develop a detection method for Alzheimer’s Disease.
MIT computer scientists are hoping to accelerate the use of artificial intelligence to improve medical decision-making, by automating a key step that’s usually done by hand — and that’s becoming more laborious as certain datasets grow ever-larger.
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) and the University of Washington in Seattle have the developed the device and said it has the potential to speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
In response to recent shutdowns of plants that use a gas called ethylene oxide to sterilize medical devices, FDA is challenging the industry to develop new approaches to device sterilization and to find ways to reduce emissions from the ethylene oxide sterilization process.
The Mountain View, CA-based company’s technology is being used in a clinical investigation that will examine whether neuromodulation could be effective as a means of managing loss-of-control eating for patients. If successful NeuroPace has the potential to shake up the obesity-treatment device market.
An industry expert outlines several keys to designing medical devices with safety in mind and addresses some of the most common blunders that threaten the development process.